Dr. Heinz-Josef Lenz

1. Dr. Heinz-Joseph Lenz. Expert op het gebied van precisiegeneeskunde voor colorectale kanker. Biografie. 0

Dr. Heinz-Josef Lenz, MD, explains the latest advances in molecular biomarkers and targeted therapies. He details how genetic profiling of tumors is revolutionizing treatment selection...

2. TAS-102 (Lonsurf) bij gevorderde darmkanker. 5-Fluorouracil is nog steeds effectieve chemotherapie bij darmkanker. 2

Dr. Heinz-Josef Lenz, MD, explains how TAS-102 (Lonsurf) offers a new treatment option for advanced colon cancer. He details the enduring importance of 5-Fluorouracil (5-FU)...

3. Darmkanker tumormarkers. Precisie geneeskunde diagnose. 3

Dr. Heinz-Josef Lenz, MD, explains how molecular tumor marker testing is essential for precision medicine in colon cancer. He details the use of KRAS, NRAS,...

4. Genezing van stadium 4 darmkanker is mogelijk. Behandeling van uitgezaaide colorectale kanker. 1

Dr. Heinz-Josef Lenz, MD, explains how a molecular revolution has transformed treatment, making cure a realistic goal for stage 4 colon cancer patients, especially those...

5. Immunotherapie van darmkanker. Wat is "moleculaire ontsnapping" van de tumor? 4

Dr. Heinz-Josef Lenz, MD, explains how molecular tumor marker testing is critical for treatment decisions. He details the concept of molecular escape, where colon cancer...

6. Vloeibare biopsie van darmkanker. Hoe de kankerbehandeling continu te monitoren. 5

Dr. Heinz-Josef Lenz, MD, explains how liquid biopsy transforms metastatic colon cancer treatment monitoring. This non-invasive blood test analyzes circulating tumor DNA and RNA to...

7. Precisiebehandeling van darmkanker. Genetica van tumor en genetica van de patiënt zijn onlosmakelijk met elkaar verbonden. 6

Dr. Heinz-Josef Lenz, MD, explains how genetic profiling of both the tumor and the patient is inseparable for optimal treatment and prevention. He details the...

8. Stamcellen bij de behandeling van darmkanker. PRI-724 chemotherapie. 7

Dr. Heinz-Josef Lenz, MD, explains how cancer stem cells cause treatment failure in metastatic colon cancer. He details a novel WNT pathway inhibitor, PRI-724, which...

9. Nieuwe gerichte chemotherapie van darmkanker. TAS-102, Stivarga, Cyramza. 8

Dr. Heinz-Josef Lenz, MD, explains how new targeted chemotherapy medications and molecular profiling are transforming advanced colon cancer treatment. He details the use of EGFR...

10. Behandeling van darmkanker door EGFR-remmers. Cetuximab (Erbitux). Panitumumab (Vectibix). 9

Dr. Heinz-Josef Lenz, MD, explains how EGFR inhibitors cetuximab and panitumumab significantly improve treatment outcomes for metastatic colon cancer patients with wild-type KRAS and NRAS...

11. Paradigmaverschuiving in de strategie van de behandeling van uitgezaaide darmkanker. 10

Dr. Heinz-Josef Lenz, MD, explains a paradigm shift in metastatic colon cancer treatment strategy. He details how cure is now a realistic goal for some...

12. Toekomst in de behandeling van colorectale kanker. Precisie geneeskunde. 11

Dr. Heinz-Josef Lenz, MD, explains how precision medicine will transform colon cancer treatment and lead to a cure. He details the future of full molecular...

Medical Practice